TRACON PHARMACEUTICALS INC's ticker is TCON and the CUSIP is 89237H100. A total of 27 filers reported holding TRACON PHARMACEUTICALS INC in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $43,000 | -34.8% | 97,673 | 0.0% | 0.00% | – |
| Q2 2019 | $66,000 | -15.4% | 97,673 | +71.4% | 0.00% | – |
| Q1 2019 | $78,000 | +11.4% | 56,974 | -50.0% | 0.00% | – |
| Q4 2018 | $70,000 | -39.7% | 113,948 | +100.0% | 0.00% | – |
| Q3 2018 | $116,000 | -24.2% | 56,974 | 0.0% | 0.00% | – |
| Q2 2018 | $153,000 | +146.8% | 56,974 | +110.6% | 0.00% | – |
| Q1 2018 | $62,000 | -31.1% | 27,057 | 0.0% | 0.00% | – |
| Q4 2017 | $90,000 | +5.9% | 27,057 | 0.0% | 0.00% | – |
| Q3 2017 | $85,000 | +32.8% | 27,057 | 0.0% | 0.00% | – |
| Q2 2017 | $64,000 | -40.2% | 27,057 | -5.8% | 0.00% | – |
| Q1 2017 | $107,000 | -23.0% | 28,710 | +0.8% | 0.00% | – |
| Q4 2016 | $139,000 | -15.8% | 28,488 | +16.5% | 0.00% | – |
| Q3 2016 | $165,000 | +55.7% | 24,457 | +0.2% | 0.00% | – |
| Q2 2016 | $106,000 | -37.6% | 24,420 | 0.0% | 0.00% | – |
| Q1 2016 | $170,000 | -24.4% | 24,420 | -0.2% | 0.00% | – |
| Q4 2015 | $225,000 | +17.8% | 24,457 | +24.6% | 0.00% | – |
| Q3 2015 | $191,000 | -8.2% | 19,626 | +6.6% | 0.00% | – |
| Q2 2015 | $208,000 | – | 18,417 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NEA Management Company, LLC | 1,889,652 | $26,531,000 | 1.20% |
| WALL STREET ASSOCIATES | 250,000 | $3,510,000 | 0.33% |
| QVT Financial LP | 368,330 | $5,001,000 | 0.28% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 485,000 | $6,809,000 | 0.22% |
| Perceptive Advisors | 100,000 | $1,404,000 | 0.11% |
| Visium Asset Management, LP | 461,336 | $6,477,000 | 0.10% |
| Opaleye Management Inc. | 12,172 | $171,000 | 0.08% |
| Candriam S.C.A. | 125,000 | $1,755,000 | 0.04% |
| Spark Investment Management LLC | 13,300 | $186,000 | 0.03% |
| Nicholas Investment Partners, LP | 30,000 | $421,000 | 0.03% |